华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

03320 华润医药

未开盘 12-23 16:08:41

5.500

+0.070

+1.29%

最高5.510	最低5.430	成交量445.96万
今开5.430	昨收5.430	日振幅1.47%
总市值345.54亿	流通市值345.54亿	总股本62.83亿
成交额2,444万	换手率0.07%	流通股本62.83亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"03320","market":"HK","secType":"STK","nameCN":"华润医药","latestPrice":5.5,"timestamp":1734941321011,"preClose":5.43,"halted":0,"volume":4459623,"delay":0,"floatShares":6282510461,"shares":6282510461,"eps":0.65222967,"marketStatus":"未开盘","marketStatusCode":0,"change":0.07,"latestTime":"12-23 16:08:41","open":5.43,"high":5.51,"low":5.43,"amount":24436797,"amplitude":0.014733,"askPrice":5.5,"askSize":47500,"bidPrice":5.49,"bidSize":16500,"shortable":3,"etf":0,"ttmEps":0.6309666468366824,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1735003800000},"adr":0,"listingDate":1477584000000,"adjPreClose":5.43,"dividendRate":0.04582,"openAndCloseTimeList":[[1734917400000,1734926400000],[1734930000000,1734940800000]],"volumeRatio":0.6867213965118372,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/03320/tweets","defaultTab":"tweets","newsList":[{"id":"2493782403","title":"南向资金12月20日持有华润医药市值20.87亿港元，持股比例占6.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493782403","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493782403?lang=zh_cn&edition=full","pubTime":"2024-12-21 07:09","pubTimestamp":1734736155,"startTime":"0","endTime":"0","summary":"12月21日，Choice数据显示，南向资金截至12月20日持有华润医药3.84亿股，持股市值20.87亿港元，较上个交易日减少706.44万港元，持股数量占发行股的6.11%。截至20日收盘，华润医药当日下跌0.55%，收盘价报5.43港元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221071431a1fefbdc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221071431a1fefbdc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","03320","BK1570"],"gpt_icon":0},{"id":"2492413783","title":"华润医药完成华润圣火51%股权转让","url":"https://stock-news.laohu8.com/highlight/detail?id=2492413783","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492413783?lang=zh_cn&edition=full","pubTime":"2024-12-20 18:46","pubTimestamp":1734691609,"startTime":"0","endTime":"0","summary":"财中社12月20日电华润医药（03320）发布完成涉及华润圣火的建议内部重组的公告。根据公告内容，华润医药在2024年12月20日宣布，子公司华润三九已完成向昆药转让华润圣火51%股权的交易，并且该交易的工商登记也已完成。此次股权转让是基于之前的股权转让协议的条款，标志着公司在内部重组方面的进一步推进。公告强调，此次重组的完成将有助于公司优化资源配置，提升整体运营效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412203274641198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2492718497","title":"华润医药：完成涉及华润圣火的建议内部重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2492718497","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492718497?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:27","pubTimestamp":1734686829,"startTime":"0","endTime":"0","summary":"格隆汇12月20日丨华润医药(03320.HK)发布公告，有关涉及公司非全资附属公司昆明华润圣火药业有限公司(“华润圣火”)的建议内部重组。2024年12月20日，根据股权转让协议的条款，华润三九建议向昆药转让华润圣火51%权益的交易已完成工商登记且该转让交易已交割完成。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220175528a1fd62f8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220175528a1fd62f8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2492491922","title":"华润医药(03320)：完成涉及华润圣火的建议内部重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2492491922","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492491922?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:15","pubTimestamp":1734686130,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)发布公告，有关涉及公司非全资附属公司昆明华润圣火药业有限公司(华润圣火)的建议内部重组。于2024年12月20日，根据股权转让协议的条款，华润三九建议向昆药转让华润圣火51%权益的交易已完成工商登记且该转让交易已交割完成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK1570","BK1191"],"gpt_icon":0},{"id":"2492919984","title":"华润医药(03320.HK)：完成涉及华润圣火内部重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2492919984","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492919984?lang=zh_cn&edition=full","pubTime":"2024-12-20 17:10","pubTimestamp":1734685800,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，于12月20日(今日)，根据股权转让协议的条款，非全资附属华润三九(000999.SZ) 建议向昆药转让华润圣火51%权益的交易已完成工商登记且该转让交易已交割完成。(ha/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-20 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20210624132644319_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20210624132644319_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405640/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1570","03320","BK1191"],"gpt_icon":0},{"id":"2492457611","title":"华润三九增资至12.8亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2492457611","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492457611?lang=zh_cn&edition=full","pubTime":"2024-12-19 16:47","pubTimestamp":1734598059,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0012","BK1515","BK0060","BK1161","BK1574","BK0185","BK0175","BK0183","03320","BK0239","09939","BK0028","BK0010","BK0188","BK1570","BK0196","BK1191","159938","000999"],"gpt_icon":0},{"id":"2492249191","title":"华润医药累计收购东阿阿胶642万股股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492249191","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492249191?lang=zh_cn&edition=full","pubTime":"2024-12-19 10:47","pubTimestamp":1734576459,"startTime":"0","endTime":"0","summary":"财中社12月19日电华润医药（03320）发布公告，宣布其全资附属公司华润医药投资有限公司于2024年11月8日至2024年12月18日期间，通过深圳证券交易所交易系统累计收购东阿阿胶股份有限公司（东阿阿胶）642万股，增持比例达到1%。此外，华润医药投资计划自2024年11月8日起六个月内继续增持东阿阿胶股份，预计增持数量不低于642万股，最高不超过771万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412193273089324.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1570","03320"],"gpt_icon":0},{"id":"2492191449","title":"华润医药附属公司累计增持华润博雅生物504万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492191449","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492191449?lang=zh_cn&edition=full","pubTime":"2024-12-19 10:47","pubTimestamp":1734576458,"startTime":"0","endTime":"0","summary":"财中社12月19日电华润医药（03320）发布公告，宣布其全资附属公司华润医药控股有限公司于2024年11月8日至2024年12月18日期间，累计收购华润博雅生物制药集团股份有限公司的股份达504万股，增持比例为1%。此次增持后，华润医药控股间接持有华润博雅生物总股本约30.28%的股份及总股本约41.59%表决权。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412193273089177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1570","03320","BK1191"],"gpt_icon":0},{"id":"2492984011","title":"华润医药(03320.HK)附属累计增持东阿阿胶1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492984011","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492984011?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:38","pubTimestamp":1734572280,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 宣布，全资附属华润医药投资于今年11月8日至12月18日期间，透过深圳证券交易所交易系统的集中竞价交易，累计增持东阿阿胶股份共约642.46股，占共总股本约1%。于增持后，目前东阿阿胶由华润医药投资持股约10.02%，并由华润医药旗下非全资附属华润东阿阿胶持股约23.56%，换言之华润医药实际控股东阿阿胶约33.58%股权。(gc/w)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-18 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115742257_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115742257_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405147/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK0183","BK0028","03320","BK0010","BK1191","BK0188","SG9999014674.SGD","BK0175","BK0196","BK1570","000423","BK0187","BK0239"],"gpt_icon":0},{"id":"2492167947","title":"金十数据整理：每日港股市场要闻速递（12月19日 周四）","url":"https://stock-news.laohu8.com/highlight/detail?id=2492167947","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492167947?lang=zh_cn&edition=full","pubTime":"2024-12-19 09:08","pubTimestamp":1734570483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["000423","GLP","06066","03377","HSCEI","MRK","SSO","US10Y.BOND","US7Y.BOND","US5Y.BOND","06963","HK0000934320.USD","US3Y.BOND","LU0234572021.USD","159891","SPXU","US2Y.BOND","LU2023250504.SGD","UPRO","BK0196","01798","LU1989772840.SGD","01963","OEF","399300","01501","601963","00639","IE00B1BXHZ80.USD","YANG","US6M.BOND","US12M.BOND","01478","03320",".SPX","OEX","SDS","07226","00012","00697","SH","HSTECH","159982","US30Y.BOND","SPY","ESmain","LU1116320901.HKD","IVV","03692","SG9999001176.USD"],"gpt_icon":0},{"id":"2492161903","title":"华润医药附属华润医药控股增持华润博雅生物股份比例达到1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492161903","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492161903?lang=zh_cn&edition=full","pubTime":"2024-12-19 08:06","pubTimestamp":1734566760,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　华润医药（03320）公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润博雅生物额外504.24万股股份，占华润博雅生物股本总额的1.00%。\n　　截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-19/doc-inczxzya0287560.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0197","BK1570","BK1191","BK0239","300294","03320","BK0046"],"gpt_icon":0},{"id":"2492516192","title":"华润医药附属华润医药投资累计增持东阿阿胶1%股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2492516192","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492516192?lang=zh_cn&edition=full","pubTime":"2024-12-19 08:05","pubTimestamp":1734566700,"startTime":"0","endTime":"0","summary":"　　华润医药公布，于2024年11月8日至2024年12月18日期间，该公司全资附属公司华润医药投资透过深圳证券交易所交易系统的集中竞价交易累计收购东阿阿胶额外约642.46万股份。　　截至本公告日期及于上述增持股份后，东阿阿胶由华润医药投资持有约10.02%股权及由该公司透过其非全资附属公司华润东阿阿胶有限公司持有约23.56%股权，且该集团实际控股东阿阿胶约33.58%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-12-19/doc-inczxzyc7064203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000423","BK0010","BK0028","BK0175","BK0183","BK0188","BK1570","BK0196","SG9999014674.SGD","03320","BK1191","BK0239","BK0187"],"gpt_icon":0},{"id":"2492139414","title":"华润医药(03320.HK)累计增持华润博雅生物1%股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2492139414","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492139414?lang=zh_cn&edition=full","pubTime":"2024-12-19 01:22","pubTimestamp":1734542520,"startTime":"0","endTime":"0","summary":"华润医药(03320.HK) 公布，11月8日至本月18日期间，透过深交所系统的集中竞价交易累计增持华润博雅生物504.24万股，占其总股本1%。增持后，公司共计持有华润博雅生物总股本41.59%表决权。公司拟自11月8日起六个月内，进一步增持华润博雅生物总股本不超过1.2%。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-18 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240827115743024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1405070/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03320","BK1191","BK1570","BK0239","300294","BK0046","BK0197"],"gpt_icon":0},{"id":"2492818120","title":"华润医药(03320)附属华润医药投资累计增持东阿阿胶1%股本","url":"https://stock-news.laohu8.com/highlight/detail?id=2492818120","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492818120?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:41","pubTimestamp":1734532899,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布，于2024年11月8日至2024年12月18日期间，该公司全资附属公司华润医药投资透过深圳证券交易所交易系统的集中竞价交易累计收购东阿阿胶额外约642.46万股份(占东阿阿胶总股本的1.00%，不包括于指定账户持有的东阿阿胶的回购股份)。截至本公告日期及于上述增持股份后，东阿阿胶由华润医药投资持有约10.02%股权及由该公司透过其非全资附属公司华润东阿阿胶有限公司持有约23.56%股权，且该集团实际控股东阿阿胶约33.58%。东阿阿胶作为该公司附属公司入账。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226798.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000423","BK1191","BK0187","BK0196","BK0239","BK0010","BK0028","BK0188","SG9999014674.SGD","BK0175","03320","BK1570","BK0183"],"gpt_icon":0},{"id":"2492018124","title":"华润医药(03320)附属华润医药控股增持华润博雅生物股份比例达到1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492018124","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492018124?lang=zh_cn&edition=full","pubTime":"2024-12-18 22:36","pubTimestamp":1734532603,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华润医药(03320)公布，于2024年11月8日至2024年12月18日期间，公司全资附属公司华润医药控股透过深圳证券交易所交易系统的集中竞价交易累计收购华润博雅生物额外504.24万股股份，占华润博雅生物股本总额的1.00%。截至本公告日期及于上述增持股份后，公司透过华润医药控股间接持有华润博雅生物总股本约30.28%及总股本约41.59%表决权。华润博雅生物作为该公司附属公司入账。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226794.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK1570","BK1191","BK0046","BK0197","BK0239","300294"],"gpt_icon":0},{"id":"2492013899","title":"博雅生物(300294.SZ)控股股东华润医药控股累计增持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492013899","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492013899?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:17","pubTimestamp":1734520671,"startTime":"0","endTime":"0","summary":"智通财经APP讯，博雅生物(300294.SZ)公告，公司控股股东华润医药控股有限公司(简称华润医药控股)于2024年11月8日-12月18日通过深圳证券交易所交易系统以集中竞价交易方式累计增持公司股份504.24万股，占公司总股本的比例为1.0000%。此外，华润医药控股自2024年11月8日起6个月内拟通过证券法规允许的方式增持公司股份，总增持股份数量(含本次已增持)不低于总股本的1%(即504.24万股)，且不超过总股本的1.2%(即605.09万股)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226681.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK0239","BK0197","BK1191","300294","BK0046","BK1570"],"gpt_icon":0},{"id":"2492904198","title":"东阿阿胶：控股股东之一致行动人累计增持1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492904198","media":"格隆汇","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492904198?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:17","pubTimestamp":1734520626,"startTime":"0","endTime":"0","summary":"格隆汇12月18日丨东阿阿胶公布，控股股东华润东阿阿胶有限公司之一致行动人华润医药投资有限公司，于2024年11月8日至2024年12月18日通过深圳证券交易所交易系统以集中竞价交易方式累计增持公司股份6,424,626股，占公司总股本的比例为1.0000%。截至2024年12月18日，华润医药投资已累计增持公司股份6,424,626股，占公司总股本的比例为1.0000%，后续拟增持不超过总股本的0.2%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218192225ab81aec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218192225ab81aec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0},{"id":"2492065909","title":"东阿阿胶(000423.SZ)控股股东之一致行动人华润医药投资累计增持公司1%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2492065909","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492065909?lang=zh_cn&edition=full","pubTime":"2024-12-18 19:11","pubTimestamp":1734520302,"startTime":"0","endTime":"0","summary":"华润医药投资拟自2024年11月8日起6个月内通过深圳证券交易所允许的方式继续增持公司股份，总增持股份数量不低于总股本的1%，且不超过总股本的1.2%。截至2024年12月18日，华润医药投资已累计增持公司股份642.46万股，占公司总股本的比例为1%，后续拟增持不超过总股本的0.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226669.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03320","BK0196","BK0188","BK1191","BK0028","BK1570","BK0183","000423","BK0239","BK0175","BK0187","SG9999014674.SGD","BK0010"],"gpt_icon":0},{"id":"2492067509","title":"东阿阿胶：控股股东之一致行动人增持公司股份达1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492067509","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492067509?lang=zh_cn&edition=full","pubTime":"2024-12-18 18:56","pubTimestamp":1734519396,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["000423","BK0010","BK0028","BK0175","BK0183","BK0188","BK1570","BK0196","SG9999014674.SGD","03320","BK1191","BK0239","BK0187"],"gpt_icon":0},{"id":"2492351674","title":"南向资金12月16日净卖出华润医药88.55万股 连续3日减持","url":"https://stock-news.laohu8.com/highlight/detail?id=2492351674","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492351674?lang=zh_cn&edition=full","pubTime":"2024-12-17 09:30","pubTimestamp":1734399021,"startTime":"0","endTime":"0","summary":"12月16日，南向资金减持华润医药88.55万股连续3日减持。截止当日收盘，港股通共持有华润医药37829.51万股，占流通股6.01%。港股通减持金额前五个股分别为腾讯控股、快手-W、中国神华、中芯国际、理想汽车-W。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093241a1f46b51&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217093241a1f46b51&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1570","BK1191","03320"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.crpharm.com","stockEarnings":[{"period":"1week","weight":0.0129},{"period":"1month","weight":0.0618},{"period":"3month","weight":0.0742},{"period":"6month","weight":-0.0498},{"period":"1year","weight":0.1589},{"period":"ytd","weight":0.0911}],"compareEarnings":[{"period":"1week","weight":0.0044},{"period":"1month","weight":0.034},{"period":"3month","weight":0.0464},{"period":"6month","weight":0.0991},{"period":"1year","weight":0.2168},{"period":"ytd","weight":0.1663}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"华润医药集团有限公司是一家香港投资控股公司。该公司及其子公司主要从事医药及其他保健品的研发、制造、分销及零售业务。该公司主要通过三大分部运营。制药分部研发、制造及销售医药及营养保健品。医药分销分部向医药制造商及配药商提供分销解决方案，如医院及其他医疗机构、分销商及零售药店。药品零售分部在中国及香港经营零售药店。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.008478},{"month":2,"riseRate":0.75,"avgChangeRate":0.055041},{"month":3,"riseRate":0.5,"avgChangeRate":-0.02417},{"month":4,"riseRate":0.875,"avgChangeRate":0.053308},{"month":5,"riseRate":0.5,"avgChangeRate":0.006748},{"month":6,"riseRate":0.375,"avgChangeRate":0.006122},{"month":7,"riseRate":0.125,"avgChangeRate":-0.056809},{"month":8,"riseRate":0.5,"avgChangeRate":0.011562},{"month":9,"riseRate":0.25,"avgChangeRate":-0.023565},{"month":10,"riseRate":0.125,"avgChangeRate":-0.03496},{"month":11,"riseRate":0.444444,"avgChangeRate":0.015631},{"month":12,"riseRate":0.555556,"avgChangeRate":0.002629}],"exchange":"SEHK","name":"华润医药","nameEN":"CHINARES PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华润医药,03320,华润医药股票,华润医药股票老虎,华润医药股票老虎国际,华润医药行情,华润医药股票行情,华润医药股价,华润医药股市,华润医药股票价格,华润医药股票交易,华润医药股票购买,华润医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华润医药(03320)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华润医药(03320)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}